1. Home
  2. Analysis
  3. Aptivus
  4. Cachexia

Aptivus and Cachexia - a phase IV clinical study of FDA data

Summary:

Cachexia is reported as a side effect among people who take Aptivus (tipranavir), especially for people who are male, 40-49 old, have been taking the drug for 2 - 5 years also take Ritonavir, and have Hiv infection.

The phase IV clinical study analyzes which people have Cachexia when taking Aptivus. It is created by eHealthMe based on reports of 1,057 people who have side effects when taking Aptivus from the FDA, and is updated regularly.

What is Aptivus?

Aptivus has active ingredients of tipranavir. eHealthMe is studying from 1,060 Aptivus users. Check the latest studies of Aptivus.

What is Cachexia?

Cachexia (loss of weight) is found to be associated with 666 drugs and 1,201 conditions by eHealthMe. Check the latest studies of Cachexia.

On Jun, 16, 2026

1,057 people reported to have side effects when taking Aptivus.
Among them, 29 people (2.74%) have Cachexia.

Could Aptivus cause Cachexia?

Among these 29 people:

How long have people been on Aptivus when they have Cachexia? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 50 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Cachexia when taking Aptivus? *

  • female: 34.48 %
  • male: 65.52 %

What is the age of people who have Cachexia when taking Aptivus? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 21.43 %
  • 30-39: 10.71 %
  • 40-49: 57.14 %
  • 50-59: 7.14 %
  • 60+: 3.57 %

What are other drugs people take besides Aptivus? *

  1. Ritonavir: 24 people, 82.76%
  2. Truvada: 22 people, 75.86%
  3. Norvir: 3 people, 10.34%
  4. Viread: 3 people, 10.34%
  5. Bactrim: 3 people, 10.34%
  6. Videx Ec: 3 people, 10.34%
  7. Epivir: 3 people, 10.34%
  8. Prezista: 3 people, 10.34%
  9. Zolpidem Tartrate: 2 people, 6.90%
  10. Atripla: 2 people, 6.90%

What are other side effects people have besides Cachexia? *

  1. Diarrhea: 21 people, 72.41%
  2. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 19 people, 65.52%
  3. Blood Bilirubin Unconjugated Increased: 16 people, 55.17%
  4. Bilirubin Conjugated Increased: 14 people, 48.28%
  5. Nausea (feeling of having an urge to vomit): 3 people, 10.34%
  6. Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 2 people, 6.90%
  7. Stress And Anxiety: 2 people, 6.90%
  8. Haematochezia (passage of stools containing blood): 2 people, 6.90%
  9. Flatulence (flatus expelled through the anus): 2 people, 6.90%
  10. Fever: 2 people, 6.90%

What are the existing conditions these people have? *

  1. Hiv Infection: 22 people, 75.86%
  2. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 9 people, 31.03%

* Approximation only. Some reports may have incomplete information.

Do you take Aptivus and have Cachexia?

- Check whether Cachexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aptivus:

Cachexia treatments and more:

How severe was Cachexia and when was it recovered:

Expand to all the drugs that have ingredients of tipranavir:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aptivus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cachexia:

Browse all the conditions that are associated with Cachexia:

How the study uses the data?

The study uses data from the FDA. It is based on tipranavir (the active ingredients of Aptivus) and Aptivus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.